Neural stimulation lead fixation
AssigneeBoston Scientific Neuromodulation Corporation
InventorsJames R. Thacker, Michael S. Colvin, David K. L. Peterson, James P. McGivern
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoston Scientific Neuromodulation Corporation
InventorsJames R. Thacker, Michael S. Colvin, David K. L. Peterson, James P. McGivern
Estimating the term…
An implantable lead having at least one electrode contact at or near its distal end prevents undesirable movement of the electrode contact from its initial implant location. One embodiment relates to a spinal cord stimulation (SCS) lead. A first injectable material is injected into the dura space to mechanically position the electrode array with respect to the spinal cord. Conjunctively for use with adhesives, or alternatively for use instead of the adhesives, a balloon may be positioned on the electrode lead array. The balloon is filled with air, liquid or a compliant material. When inflated, the balloon stabilizes the lead with respect to the spinal cord and holds the lead in place. An elastic aspect of the balloon serves as an internal contained relief valve to limit the pressure the balloon may place on the surrounding tissues when the epidural space is constrained.
An implantable neural lead having a distal end, comprising:
A method of implanting a lead, the method comprising:
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Spinal or peripheral nerve electrodes: anchoring or fixation means therefor
Balloon catheters: characterised by balloon shape
Balloon catheters: multiple balloon catheters
Electrotherapy
Term ended 24 May 2022 (estimated)
The present invention relates to a neural stimulation systems, e.g., a spinal cord stimulation system. More particularly, the invention relates to neural stimulation leads that include lead fixation means, i.e., ways to assure that the lead, once implanted, does not move away from its desired implant location.
Spinal cord stimulation (SOS) is a well accepted clinical method for reducing pain in certain populations of patients. SCS systems typically include an implanted pulse generator, lead wires, and electrodes connected to the lead wires. The pulse generator generates electrical pulses that are delivered to the dorsal column fibers within the spinal cord through the electrodes which are implanted along the dura of the spinal cord. In a typical situation, the attached lead wires exit the spinal cord and are tunneled around the torso of the patient to a sub-cutaneous pocket where the pulse generator is implanted.
When an electrical pulse, or sequence of pulses, is applied to a selected electrode, or combination of electrodes, the patient typically experiences a “paresthesia” (usually manifest as a mild tingling sensation) that is therapeutic, i.e., that relieves the pain, or other discomfort, the patient is experiencing, or that otherwise aids the patient in some useful way.
The above and other aspects, features and advantages of the teachings of the present disclosure will be more apparent from the following more particular description thereof, presented in conjunction with the following drawings wherein;
FIG. 1 illustrates a representative spinal cord stimulation system implanted in a patient;
FIG. 2 is a sectional view that depicts the electrode array as taught by the present disclosure implanted adjacent the spine;
Corresponding reference characters indicate corresponding components throughout the several views of the drawings.
The following description is of the best mode presently contemplated for carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of describing the general principles of the invention. The scope of the invention should be determined with reference to the claims.
At the outset, it should be noted that the teachings of the present disclosure are directed to the fixation of implantable leads, such as neural stimulation leads or cardiac leads, and more particularly to the fixation of electrodes, or electrode arrays, attached to neural stimulation leads or cardiac leads so that such electrodes, or electrode arrays, remain in a desired position relative to the tissue that is to be stimulated. For purposes of the present disclosure, the terms “lead” and “electrode” and “electrode array” may thus be used interchangeably, unless the context clearly indicates otherwise. That is, while the narrow purpose of the present discloure is to fix the electrodes relative to the tissue to be stimulated, in describing such purpose other terminology may be used, such as fixing the lead, or fixing the electrode array.